Pricing
Login
Home
Charts
Search
Watchlist
Products

Morepen Laboratories Ltd

MOREPENLAB
₹90.15-0.68%20 Nov 2026
Reports
Pharma API

Morepen Laboratories Ltd

MOREPENLAB
₹90.15
-0.68%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹4,940Cr
Close
Close Price
₹90.15
Industry
Industry
Pharma API
PE
Price To Earnings
26.28
PS
Price To Sales
2.16
Revenue
Revenue
₹2,286Cr
Rev Gr TTM
Revenue Growth TTM
30.20%
PAT Gr TTM
PAT Growth TTM
89.48%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
445423455438453466425412484485570747
Growth YoY
Revenue Growth YoY%
27.616.313.53.81.910.1-6.6-6.06.94.034.181.4
Expenses
ExpensesCr
394375404394417424401381438460488623
Operating Profit
Operating ProfitCr
5148524436422431462483123
OPM
OPM%
11.411.411.310.18.09.15.77.59.65.014.516.5
Other Income
Other IncomeCr
4435554304859
Interest Expense
Interest ExpenseCr
211115444455
Depreciation
DepreciationCr
81062516911106810
PBT
PBTCr
4442484635261646352375117
Tax
TaxCr
121312119545881828
PAT
PATCr
322936352720114128165689
Growth YoY
PAT Growth YoY%
255.8248.8147.263.9-16.6-29.3-68.517.83.0-22.7393.9116.6
NPM
NPM%
7.26.88.08.05.94.42.710.05.73.29.911.9
EPS
EPS₹
0.60.50.70.70.50.30.20.80.50.31.01.6
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
445423455438453466425412484485570747
Growth YoY
Revenue Growth YoY%
27.616.313.53.81.910.1-6.6-6.06.94.034.181.4
Expenses
ExpensesCr
394375404394417424401381438460488623
Operating Profit
Operating ProfitCr
5148524436422431462483123
OPM
OPM%
11.411.411.310.18.09.15.77.59.65.014.516.5
Other Income
Other IncomeCr
4435554304859
Interest Expense
Interest ExpenseCr
211115444455
Depreciation
DepreciationCr
81062516911106810
PBT
PBTCr
4442484635261646352375117
Tax
TaxCr
121312119545881828
PAT
PATCr
322936352720114128165689
Growth YoY
PAT Growth YoY%
255.8248.8147.263.9-16.6-29.3-68.517.83.0-22.7393.9116.6
NPM
NPM%
7.26.88.08.05.94.42.710.05.73.29.911.9
EPS
EPS₹
0.60.50.70.70.50.30.20.80.50.31.01.6

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
4855956077698531,1881,5471,4181,6901,8121,8062,286
Growth
Revenue Growth%
21.122.81.926.711.039.330.2-8.419.37.2-0.330.2
Expenses
ExpensesCr
4245345427017851,0701,4101,3381,5321,6381,6802,009
Operating Profit
Operating ProfitCr
626165686911913780159174126276
OPM
OPM%
12.710.310.78.88.010.08.85.69.49.67.012.1
Other Income
Other IncomeCr
144491210614184726
Interest Expense
Interest ExpenseCr
1184222-72481618
Depreciation
DepreciationCr
353434403730282833293635
PBT
PBTCr
13243029399912756135155120250
Tax
TaxCr
000061251739372461
PAT
PATCr
132430293497102399711896188
Growth
PAT Growth%
497.584.626.0-3.116.4189.14.7-62.0149.822.1-18.989.5
NPM
NPM%
2.64.04.93.83.98.26.62.75.76.55.38.2
EPS
EPS₹
0.30.50.70.60.82.22.30.81.92.21.73.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
4855956077698531,1881,5471,4181,6901,8121,8062,286
Growth
Revenue Growth%
21.122.81.926.711.039.330.2-8.419.37.2-0.330.2
Expenses
ExpensesCr
4245345427017851,0701,4101,3381,5321,6381,6802,009
Operating Profit
Operating ProfitCr
626165686911913780159174126276
OPM
OPM%
12.710.310.78.88.010.08.85.69.49.67.012.1
Other Income
Other IncomeCr
144491210614184726
Interest Expense
Interest ExpenseCr
1184222-72481618
Depreciation
DepreciationCr
353434403730282833293635
PBT
PBTCr
13243029399912756135155120250
Tax
TaxCr
000061251739372461
PAT
PATCr
132430293497102399711896188
Growth
PAT Growth%
497.584.626.0-3.116.4189.14.7-62.0149.822.1-18.989.5
NPM
NPM%
2.64.04.93.83.98.26.62.75.76.55.38.2
EPS
EPS₹
0.30.50.70.60.82.22.30.81.92.21.73.4
Sales CAGR
1 Year0%
3 Years8%
5 Years9%
TTM30%
EBITDA CAGR
1 Year-28%
3 Years16%
5 Years1%
TTM107%
PAT CAGR
1 Year-19%
3 Years35%
5 Years0%
TTM89%
Avg. ROCE
1 Year9%
3 Years13%
5 Years13%
TTM16%
CFO / EBITDA
1 Year26%
3 Years30%
5 Years-2%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
90909090909096102102110110110
Reserves
ReservesCr
911061361631942914576517451,0471,1371,272
Current Liabilities
Current LiabilitiesCr
167325340339351404456321402501490726
Non Current Liabilities
Non Current LiabilitiesCr
57182023283036374490199198
Total Liabilities
Total LiabilitiesCr
5245385866156638581,0701,1111,2931,7781,9362,306
Current Assets
Current AssetsCr
1571922432993725277347568891,1591,1641,440
Non Current Assets
Non Current AssetsCr
367346342316291331336354404619773866
Total Assets
Total AssetsCr
5245385866156638581,0701,1111,2931,7781,9362,306
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
90909090909096102102110110110
Reserves
ReservesCr
911061361631942914576517451,0471,1371,272
Current Liabilities
Current LiabilitiesCr
167325340339351404456321402501490726
Non Current Liabilities
Non Current LiabilitiesCr
57182023283036374490199198
Total Liabilities
Total LiabilitiesCr
5245385866156638581,0701,1111,2931,7781,9362,306
Current Assets
Current AssetsCr
1571922432993725277347568891,1591,1641,440
Non Current Assets
Non Current AssetsCr
367346342316291331336354404619773866
Total Assets
Total AssetsCr
5245385866156638581,0701,1111,2931,7781,9362,306

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
504163171151-60-91733233
Investing Cash Flow
Investing Cash FlowCr
-27-14-27-13-12-70-32-47-83-322-123
Financing Cash Flow
Financing Cash FlowCr
-27-24-38054766144530097
Net Cash Flow
Net Cash FlowCr
-43-14428-266-5107
Free Cash Flow
Free Cash FlowCr
4131539-629-106-1272-92-52
CFO To PAT
CFO To PAT%
391.2172.3213.060.232.852.4-59.2-235.775.927.234.1
CFO To EBITDA
CFO To EBITDA%
81.366.398.025.716.142.9-44.1-114.646.318.426.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
504163171151-60-91733233
Investing Cash Flow
Investing Cash FlowCr
-27-14-27-13-12-70-32-47-83-322-123
Financing Cash Flow
Financing Cash FlowCr
-27-24-38054766144530097
Net Cash Flow
Net Cash FlowCr
-43-14428-266-5107
Free Cash Flow
Free Cash FlowCr
4131539-629-106-1272-92-52
CFO To PAT
CFO To PAT%
391.2172.3213.060.232.852.4-59.2-235.775.927.234.1
CFO To EBITDA
CFO To EBITDA%
81.366.398.025.716.142.9-44.1-114.646.318.426.0

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,1748551,3887764291,4461,7491,3132,1502,6221,8524,940
Price To Earnings
Price To Earnings
93.235.946.726.912.714.917.233.822.422.319.526.3
Price To Sales
Price To Sales
2.41.42.31.00.51.21.10.91.31.41.02.2
Price To Book
Price To Book
6.54.46.23.11.53.83.21.72.52.31.53.6
EV To EBITDA
EV To EBITDA
19.713.821.411.25.911.812.616.113.415.415.818.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
35.636.136.532.632.232.329.729.332.730.931.831.8
OPM
OPM%
12.710.310.78.88.010.08.85.69.49.67.012.1
NPM
NPM%
2.64.04.93.83.98.26.62.75.76.55.38.2
ROCE
ROCE%
10.315.814.911.813.925.220.97.415.913.09.415.9
ROE
ROE%
7.112.013.211.411.825.518.45.111.410.27.713.6
ROA
ROA%
2.44.45.14.75.111.39.53.57.56.64.98.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,1748551,3887764291,4461,7491,3132,1502,6221,8524,940
Price To Earnings
Price To Earnings
93.235.946.726.912.714.917.233.822.422.319.526.3
Price To Sales
Price To Sales
2.41.42.31.00.51.21.10.91.31.41.02.2
Price To Book
Price To Book
6.54.46.23.11.53.83.21.72.52.31.53.6
EV To EBITDA
EV To EBITDA
19.713.821.411.25.911.812.616.113.415.415.818.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
35.636.136.532.632.232.329.729.332.730.931.831.8
OPM
OPM%
12.710.310.78.88.010.08.85.69.49.67.012.1
NPM
NPM%
2.64.04.93.83.98.26.62.75.76.55.38.2
ROCE
ROCE%
10.315.814.911.813.925.220.97.415.913.09.415.9
ROE
ROE%
7.112.013.211.411.825.518.45.111.410.27.713.6
ROA
ROA%
2.44.45.14.75.111.39.53.57.56.64.98.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr5,7515,4044,9914,9404,5904,4324,422
Close PriceClose₹960.40184.12620.1590.15352.70473.25484.50
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE134.7026.6128.1826.28213.7637.3819.34
Price To SalesPS4.711.965.682.1627.684.561.55
RevenueRevenueCr1,2212,7518792,2861669712,851
Revenue Growth TTMRev Gr TTM%20.1%26.8%23.0%30.2%13.0%15.1%
PAT Growth TTMPAT Gr TTM%16.5%75.4%-2.8%89.5%28.3%14.9%
Market CapitalizationMkt CapCr5,7515,4044,9914,9404,5904,4324,422
Close PriceClose₹960.40184.12620.1590.15352.70473.25484.50
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE134.7026.6128.1826.28213.7637.3819.34
Price To SalesPS4.711.965.682.1627.684.561.55
RevenueRevenueCr1,2212,7518792,2861669712,851
Revenue Growth TTMRev Gr TTM%20.1%26.8%23.0%30.2%13.0%15.1%
PAT Growth TTMPAT Gr TTM%16.5%75.4%-2.8%89.5%28.3%14.9%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
ResultPPT
Transcript
Summary
Jun 26
ResultPPT
Transcript
Summary
Mar 26
ResultPPT
Transcript
Summary
Dec 25
ResultPPT
Transcript
Summary
Sep 25
ResultPPT
Transcript
Summary
Jun 25
ResultPPT
Transcript
Summary
Jun 23
ResultPPT
Transcript
Summary
Mar 23
ResultPPT
Transcript
Summary
Dec 22
ResultPPT
Transcript
Summary
Sep 22
ResultPPT
Transcript
Summary
Jun 22
ResultPPT
Transcript
Summary
Dec 21
Sep 21
Jun 21
Mar 21
Dec 20
Sep 20
Jun 20
Result
PPTTranscript
Summary
Annual Reports
Quarterly Reports
Sep 26
ResultPPT
Transcript
Summary
Jun 26
ResultPPT
Transcript
Summary
Mar 26
ResultPPT
Transcript
Summary
Dec 25
ResultPPT
Transcript
Summary
Sep 25
ResultPPT
Transcript
Summary
Jun 25
ResultPPT
Transcript
Summary
Jun 23
ResultPPT
Transcript
Summary
Mar 23
ResultPPT
Transcript
Summary
Dec 22
ResultPPT
Transcript
Summary
Sep 22
ResultPPT
Transcript
Summary
Jun 22
ResultPPT
Transcript
Summary
Dec 21
Sep 21
Jun 21
Mar 21
Dec 20
Sep 20
Jun 20
Result
PPTTranscript
Summary
Load More
Interviews